EF Hutton Reiterates Buy on Agenus, Maintains $8.3 Price Target
EF Hutton analyst Michael King reiterates Agenus (NASDAQ:AGEN) with a Buy and maintains $8.3 price target.
Agenus Q4 EPS $(0.24) Misses $(0.22) Estimate, Sales $28.39M Beat $17.83M Estimate
Agenus (NASDAQ:AGEN) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 7.69 percent increase over losses of $(0.26) per share from the same
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
Agenus Inc (NASDAQ:AGEN) announced clinical data from the MSS CRC (microsatellite stable colorectal cancer) 70 patient cohort of a Phase 1b…
Benzinga’s Top Ratings Upgrades, Downgrades For December 22, 2022
Upgrades According to DA Davidson, the prior rating for Helen Of Troy Ltd (NASDAQ:HELE) was changed from Neutral…
EF Hutton Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $8.3
EF Hutton analyst Michael King initiates coverage on Agenus (NASDAQ:AGEN) with a Buy rating and announces Price Target of $8.3.
Miniso Group, Monday.com And Other Big Gainers From Monday
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers
Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.